Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001477932-25-008186
Filing Date
2025-11-13
Accepted
2025-11-13 16:18:25
Documents
81
Period of Report
2025-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q vnrx_10q.htm   iXBRL 10-Q 1905411
2 FORM OF WARRENT vnrx_ex43.htm EX-4.3 64777
3 CERTIFICATION vnrx_ex311.htm EX-31.1 13147
4 CERTIFICATION vnrx_ex312.htm EX-31.2 13480
5 CERTIFICATION vnrx_ex321.htm EX-32.1 6234
  Complete submission text file 0001477932-25-008186.txt   9450091

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA vnrx-20250930.xsd EX-101.SCH 98572
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE vnrx-20250930_lab.xml EX-101.LAB 479122
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE vnrx-20250930_cal.xml EX-101.CAL 59667
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vnrx-20250930_pre.xml EX-101.PRE 463438
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vnrx-20250930_def.xml EX-101.DEF 340548
85 EXTRACTED XBRL INSTANCE DOCUMENT vnrx_10q_htm.xml XML 1885120
Mailing Address 1489 WEST WARM SPRINGS ROAD SUITE 110 HENDERSON NV 89014
Business Address 1489 WEST WARM SPRINGS ROAD SUITE 110 HENDERSON NV 89014 1 (646) 650-1351
VOLITIONRX LTD (Filer) CIK: 0000093314 (see all company filings)

EIN.: 911949078 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36833 | Film No.: 251478787
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)